Product Images Carvedilol
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Carvedilol NDC 0904-7306 by Major Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
figure-1 - figure 1
This appears to be a description showing a comparison between Placebo and Carvedilol at different time points, such as 3, 6, 9, 12, 15, 18, and 21 months. The statistical significance is indicated with a p-value of 0.0014.*
figure-2 - figure 2
This appears to be a list of criteria or variables related to a study or analysis involving men and women with different characteristics such as age, race, health conditions, and physiological parameters like heart rate and blood pressure. The text also includes terms like Spironolactione, hazard ratio, and statistical symbols. These variables may be used to analyze and compare different groups of patients based on the outlined criteria.*
figure-3 - figure 3
This text shows survival analysis results for the CAPRICORN study comparing placebo and carvedilol in an intent-to-treat analysis. It indicates a statistically significant difference in mortality between the two groups, with a p-value of 0.03. The graph depicts the survival rates over a 24-month period.*
figure-4 - figure 4
This description provides insights on the effects of various subgroups on mortality in the CAPRICORN study. It includes details such as age criteria, gender differences, use of diuretics, presence of angina, hypertension, diabetes, heart rate, thrombolytic therapy, blood pressure levels, and PTCA for myocardial infarction. The text appears to present data on Hazard Ratios for different factors in relation to mortality outcomes.*
3.125mg carton label - image 01
25mg carton label - image 02
This text is a description of Carvedilol Tablets, USP in a package containing 100 tablets. It mentions storage instructions at 20 to 25°C, the importance of using safety closures when dispensing, and that the product meets USP Dissolution Test 2. The packaging emphasizes that it is child-resistant and intended for institutional use only. The drug is associated with NEC's Shear 155 Clancy Pharmaceuticals and is packaged and distributed by ALK Pharmaceuticals.*
logo - logo
logo1 - logo1
carvedilol-chemical-structure - structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
